NeuroPace raises 2025 revenue guidance to $94M-$98M as RNS System drives record growth
Source: SeekingAlpha
2025-08-12 21:51:27 ET
More on NeuroPace
- NeuroPace, Inc. 2025 Q2 - Results - Earnings Call Presentation
- NeuroPace, Inc. (NPCE) Q2 2025 Earnings Call Transcript
- NeuroPace: Volatile, Uncertain, But Promising
- NeuroPace secures $75M credit facility with MidCap Financial
- NeuroPace falls after setback in trial for neuromodulation system
Read the full article on Seeking Alpha
For further details see:
NeuroPace raises 2025 revenue guidance to $94M-$98M as RNS System drives record growth
Neuropace Inc.
NASDAQ: NPCE
NPCE Trading
1.3% G/L:
$14.415 Last:
78,208 Volume:
$14.17 Open:
NPCE Latest News
March 03, 2026 04:05:00 pm
NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook
NPCE Stock Data
$508,942,176
26,479,649
0.24%
22
N/A
Medical Equipment & Supplies
Healthcare
US
Mountain View
